Innovative Research Award
Min-Shi Lee — National Health Research Institutes, Taiwan
Min-Shi Lee is an infectious-disease researcher at the National Health Research Institutes in Taiwan whose work spans epidemiology, virology, vaccinology, assay development, and bioinformatics. Her publication record addresses enteroviruses, influenza viruses, vaccine development, surveillance, viral characterization, and pandemic preparedness. Research contributions include studies of EV-A71 epidemiology, enterovirus surveillance networks, influenza vaccine viruses, recombinant hemagglutinin immunogenicity, and genomic approaches for identifying recombinant enteroviruses. Recent work has examined monoclonal antibodies for monitoring EV-A71 vaccine potency. Collectively, these studies connect laboratory investigation with surveillance and translational vaccine research relevant to infectious-disease prevention, preparedness, and public-health decision-making nationally and internationally.
Abstract
Min-Shi Lee is an infectious-disease researcher at the National Health Research Institutes in Taiwan whose work spans epidemiology, virology, vaccinology, assay development, and bioinformatics. Her publication record addresses enteroviruses, influenza viruses, vaccine development, surveillance, viral characterization, and pandemic preparedness. Research contributions include studies of EV-A71 epidemiology, enterovirus surveillance networks, influenza vaccine viruses, recombinant hemagglutinin immunogenicity, and genomic approaches for identifying recombinant enteroviruses. Recent work has examined monoclonal antibodies for monitoring EV-A71 vaccine potency. Collectively, these studies connect laboratory investigation with surveillance and translational vaccine research relevant to infectious-disease prevention, preparedness, and public-health decision-making nationally and internationally in practice and policy.
Keywords
Min-Shi Lee’s publication-based keywords include enterovirus 71, EV-A71, enterovirus surveillance, influenza H5N1, influenza H5N2, influenza H7N9, vaccine development, vaccine potency, immunogenicity, recombinant hemagglutinin, monoclonal antibodies, viral genomics, genome sequencing, recombinant enteroviruses, epidemiology, virology, vaccinology, assay development, pandemic preparedness, molecular surveillance, seroprevalence, antiviral research, vaccine viruses, emerging viruses, and infectious-disease prevention.
Introduction
Min-Shi Lee’s research career at the National Health Research Institutes centers on emerging infectious viruses and vaccine science. Institutional records identify expertise in epidemiology, vaccinology, virology, infectious diseases, vaccine development, assay development, and bioinformatics. Her work combines epidemiological surveillance with laboratory investigation to address emerging viral threats and practice. [2]
Research Profile
Min-Shi Lee has worked with the NHRI since 2005 and currently serves as an investigator in its National Institute of Infectious Diseases and Vaccinology. Her professional background includes epidemiology and vaccine research, while institutional activities emphasize emerging viruses, influenza, enteroviruses, surveillance, and collaborative infectious-disease research across Asia-Pacific partnerships across regions. [2]
Research Contributions
Min-Shi Lee has contributed to research on EV-A71 surveillance and vaccine evaluation, influenza H5N1, H5N2, and H7N9 vaccine development, and molecular characterization of enteroviruses. Her publications also address recombinant viral vaccine production, immunogenicity, antibody development, and genomic sequencing, illustrating an integrated approach linking virology, epidemiology, laboratory methods, and translational vaccinology. [3] [4] [5]
Publications
Min-Shi Lee’s indexed publications include studies of EV-A71 vaccine licensure challenges, influenza H5N1 vaccine-virus adaptation, H7N9 recombinant hemagglutinin immunogenicity, enterovirus surveillance, recombinant-enterovirus genome sequencing, and EV-A71 monoclonal antibodies. Representative articles have appeared in PLOS Neglected Tropical Diseases, PLOS ONE, Vaccine, Microbiology Spectrum, and related infectious-disease journals of interest. [3] [4] [5]
Research Impact
Min-Shi Lee’s research impact is reflected in a substantial indexed publication record and in collaborative surveillance and vaccine-development studies. Her work has supported understanding of enterovirus epidemiology, influenza vaccine preparedness, and laboratory methods for viral monitoring. The research also contributes evidence relevant to vaccine potency assessment and emerging-virus preparedness activities. [1] [2]
Award Suitability
Min-Shi Lee’s profile is suitable for an innovative research recognition focused on infectious diseases because her work connects epidemiological surveillance, virology, vaccine development, and translational assay research. Her publications demonstrate sustained engagement with emerging viral threats and collaborative scientific programs, providing a basis for recognizing contributions to infectious-disease research. [2] [3] [4]
Conclusion
Min-Shi Lee represents a research profile focused on infectious diseases, virology, epidemiology, and vaccinology, with publications spanning enteroviruses, influenza viruses, surveillance, vaccine development, and molecular methods. Her work demonstrates continuity between public-health questions and laboratory research, while collaborative studies extend its relevance to surveillance, vaccine preparedness, and infectious-disease control strategies. [1] [2]
External Links
References
- Elsevier. (n.d.). Scopus author details: Min-Shi Lee, Author ID 26659600600. ScienceDirect/Scopus author profile.
https://www.sciencedirect.com/author/26659600600/min-shi-lee
- National Health Research Institutes. (n.d.). Researcher: Min-Shi Lee. National Institute of Infectious Diseases and Vaccinology, Taiwan.
https://iv.nhri.edu.tw/研究人員/李敏西/
- Le, T.-H.-L., Weng, T.-Y., Yen, H., Chia, M.-Y., & Lee, M.-S. (2025). Development of a novel EV-A71 monoclonal antibody for monitoring vaccine potency. PLOS Neglected Tropical Diseases, 19(6), e0013127.
https://doi.org/10.1371/journal.pntd.0013127
- Chien, Y.-S., et al. (2023). Cost-effective complete genome sequencing using the MinION platform for identification of recombinant enteroviruses. Microbiology Spectrum.
https://doi.org/10.1128/spectrum.02507-23
- Lin, T.-H., Chia, M.-Y., Lin, C.-Y., Yeh, Y.-Q., Jeng, U.-S., Wu, W.-G., & Lee, M.-S. (2019). Improving immunogenicity of influenza virus H7N9 recombinant hemagglutinin for vaccine development. Vaccine, 37(13), 1897–1903.
https://doi.org/10.1016/j.vaccine.2018.09.034